Insmed Incorporated

INSM11 Dec 2024
Healthcare
$73.14
0.00 (-0.21%)
Lowest Today
$72.16
Highest Today
$73.95
Today’s Open
$73.14
Prev. Close
$72.77
52 Week High
$80.53
52 Week Low
$21.92
To Invest in Insmed Incorporated

Insmed Incorporated

Healthcare
INSM11 Dec 2024
0.00 (-0.21%)
1M
3M
6M
1Y
5Y
Low
$72.16
Day’s Range
High
$73.95
72.16
52 Week Low
$21.92
52-Week Range
52 Week High
$80.53
21.92
1 Day
-
1 Week
-3.81%
1 month return
+1.11%
3 month return
-0.21%
6 month return
+17.46%
1 Year return
+166.51%
3 Years return
+169.23%
5 Years return
+218.31%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
9.58
BlackRock Inc
7.97
T. Rowe Price Associates, Inc.
7.03
Darwin Global Management, Ltd.
5.87
FMR Inc
4.02
Capital Research & Mgmt Co - Division 3
3.65
State Street Corp
3.45

Market Status

Fundamentals
Market Cap
13018.77 mln
PB Ratio
27.9
PE Ratio
0
Enterprise Value
13021.23 mln
Total Assets
1329.84 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Organisation
Insmed Incorporated
Employees
912
Industry
Biotechnology
CEO
Mr. William H. Lewis J.D., M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step